Early discharge in the thrombolytic era: An analysis of criteria for uncomplicated infarction from the global utilization of streptokinase and t-PA for occluded coronary arteries (GUSTO) trial

L. Kristin Newby, Robert M. Califf, Alan D. Guerci, +8

Journal of the American College of Cardiology

ThrombosisCardiovascular DiseaseGlobal UtilizationOccluded Coronary ArteriesCardiology +8

Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts

Koon-Hou Mak, Ram Challapalli, Mark J. Eisenberg, +4

The American Journal of Cardiology

ThrombosisCardiovascular DiseaseBlood PlateletVascular SurgeryVascular Biology +8

Effects of profound platelet inhibition with c7E3 before coronary angioplasty on complications of coronary bypass surgery

James D. Boehrer, Dean J. Kereiakes, Frank I. Navetta, +3

The American Journal of Cardiology

ThrombopoiesisThrombosisPercutaneous Coronary InterventionCoronary Bypass SurgeryProfound Platelet Inhibition +9

Selection of thrombolytic therapy for individual patients: Development of a clinical model

Robert M. Califf, Lynn H. Woodlief, Frank E. Harrell, +8

American Heart Journal

ThrombosisHemodialysisIndividual PatientsVenous ThrombosisCardiovascular Disease +12

Painless exercise ST deviation on the treadmill: Long-term prognosis

Daniel B. Mark, Mark A. Hlatky, Robert M. Califf, +6

Journal of the American College of Cardiology

Physical ActivityKinesiologyExerciseExercise PhysiologyChronic Musculoskeletal Condition +5

A randomized trial of intravenous heparin in conjunction with anistreplase (anisoylated plasminogen streptokinase activator complex) in acute myocardial infarction: The Duke University clinical cardiology study (DUCCS) 1

Christopher M. O’Connor, Roderick B. Meese, Robert J. Carney, +13

Journal of the American College of Cardiology

ThrombosisIntravenous HeparinCardiovascular DiseaseMyocardial InfarctionRandomized Trial +9

Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy

Joseph A Puma, Michael H. Sketch, Trevor Thompson, +5

The American Journal of Cardiology

ThrombosisVenous ThrombosisOpen-artery HypothesisCardiovascular DiseaseThrombolytic Therapy +8

Negative T waves shortly after ST-elevation acute myocardial infarction are a powerful marker for improved survival rate

Elena B. Sgarbossa, Peter Meyer, Sergio L. Pinski, +9

American Heart Journal

Cardiogenic ShockCardiovascular DiseaseImproved Survival RateMyocardial InfarctionPowerful Marker +6

A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction

Christopher M. O’Connor, Roderick B. Meese, Steven E. McNulty, +13

The American Journal of Cardiology

ThrombosisCardiovascular DiseaseMedicineAnticoagulantPharmacotherapy +8

Tissue plasminogen activator: why the backlash?

Eric J. Topol, Robert M. Califf

Journal of the American College of Cardiology

Human TissueTissue Plasminogen ActivatorVascular BiologyWound HealingTissue Culture +4